Trial Profile
Efficacy of Vonoprazan for Protonpump inhibitor resistant sleeping disorder caused by gastroesophageal reflux disease (GERD) symptoms.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Mar 2017
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 20 Mar 2017 Status changed from not yet recruiting to recruiting.
- 02 Jun 2016 New trial record